This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Jul;9(7):646-7.

doi: 10.1016/S1474-4422(10)70134-4. Epub 2010 Jun 9.

Improving combination trials for multiple sclerosis

PMID: 20542737
DOI: 10.1016/S1474-4422(10)70134-4

Comment

Improving combination trials for multiple sclerosis

Maria Trojano. Lancet Neurol. 2010 Jul.

. 2010 Jul;9(7):646-7.

doi: 10.1016/S1474-4422(10)70134-4. Epub 2010 Jun 9.

Author

PMID: 20542737
DOI: 10.1016/S1474-4422(10)70134-4

No abstract available

PubMed Disclaimer

Comment on

Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial.
Ravnborg M, Sørensen PS, Andersson M, Celius EG, Jongen PJ, Elovaara I, Bartholomé E, Constantinescu CS, Beer K, Garde E, Sperling B. Ravnborg M, et al. Lancet Neurol. 2010 Jul;9(7):672-80. doi: 10.1016/S1474-4422(10)70132-0. Epub 2010 Jun 9. Lancet Neurol. 2010. PMID: 20542736 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information